NSF Still Wrestling With Science Board Over Recommendations For Agency Future

NSB report's ambiguity and a lack of consensus on implementation hamper foundation's strategic planning In the face of congressional pressures and a climate of unease among university-based researchers, the National Science Foundation and its oversight body, the National Science Board, are wrestling to develop a plan for implementing policy recommendations set forth in a report by a special NSB commission on the agency's future. Their efforts are being complicated by lack of consensus about h

Written byBarton Reppert
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Their efforts are being complicated by lack of consensus about how to interpret the commission's findings in areas such as the relationship of basic and applied science, grant allocations, science education, and NSF's role in developing a national science and technology policy. There has also been disagreement between NSB and NSF director Walter E. Massey over the role the science board should play in shaping specific agency policy initiatives.

Following are excerpts from the report, "A Foundation for the 21st Century: A Progressive Framework for the National Science Foundation," prepared by the National Science Board's Commission on the Future of the National Science Foundation. The report was released on Nov. 20, 1992. "Despite having only about three percent of the total federal R&D budget, the NSF has for over 40 years played an essential role in the scientific primacy of the United States.... "An important national priority is to improve ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies